Significantly higher levels of uPA and PAI-1, along with the Thomsen–Friedenreich antigen, have been reported in NAF of women with cancer, with the former more predictive for postmenopausal and the latter more indicative for premenopausal patients [111]. The gene discussed is PLAU; the disease is cancer.